Acta Pharmaceuticals
Boston, US · Founded 2022 · Delaware corporation
Founders & leadership
GA
George AlexNamed on SEC filing
TP
Thierry PorteNamed on SEC filing
RT
Rudolph TanziNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$13.4M disclosed across 1 round · 2023
▶$13.4MraisedApr 2024 · 29 investors · PharmaceuticalsRule 506(b)
▶$13.4MraisedApr 2024 · 29 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- George AlexExecutive Officer, Director
- Thierry PorteDirector
- Rudolph TanziDirector
- Offering amount
- $17.5M
- Amount sold
- $13.4M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Acta Pharmaceuticals raised?
- Acta Pharmaceuticals has disclosed $13.4M raised across 1 round.
- Where is Acta Pharmaceuticals headquartered?
- Acta Pharmaceuticals is headquartered in Boston, US.